Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 1998

The microbiological profile of bacterial infections seen in surgical intensive care units (ICU)

Antoni M. Szczepanik, Lucyna Polakiewicz, Jerzy P. Wordliczek, Aldona Kubisz, Jarosław B. Garlicki

Med Sci Monit 1998; 4(5): CR807-810 :: ID: 502004

Abstract

Infections are the main problem encountered in intensive care units (ICU). They may be considered as primary,leading to the admission of patients to the ICU or as hospital acquired infection complications. We analyzed the microbiological material of patients treated during the period of 1993-1995, in whom we diagnosed infections of various location. During this period, we treated 582 patients, 74% following surgical procedures.Primary and acquired infections were noted in 262 patients, out of which 36 had more than one infection focus. In 44% of cases, cultures demonstrated the presence of more than one pathogen. Pulmonary infections composed 42% of all infections, intraabdominal infections - 27%, urinary tract infections - 9%, infections accompanying the use of intravenous catheters - 8%, wound infections - 6% and other infections - 8%. Most often, we isolated gram negative (E. coli, pseudomonas aeruginosa) bacteria from cultures, but the percentage of gram positive bacteria had increased during the three year period from 17.3 to 25%. Out of Pseudomonas strains, the resistance profile changed with time. During the first year of observation, we noted single cases of resistance towards imipinem, while resistance towards other antibiotics, such as ceftazidim was 20% and quinolones and aminoglycosides 30-45%. In 1995 the resistance towards imipenem increased to 16.6%, for ciprofloxacine - 58% and in the case of aminoglycosides 30-35%. The biggest group out of pluriresistant strains comprised the Enterococcus strains, although we found no vancomycin resistant strain. We observed an increase in resistance towards quinolones (pefloxacin and ciprofloxacin).

Keywords: Intensive Care Units

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750